For paediatric patients the use of a centile chart is recommended. No additional benefit has been demonstrated for doses higher than 1.2 mg/kg/day. B2) B.P. They can then talk to your doctor.
If you feel tired, sleepy or dizzy you should not drive or operate machinery.This oral solution can irritate the eye. Hands and any other part of the body that may have come into contact with the oral solution should also be washed as soon as possible.This medicine contains 32.97 mg sorbitol in each mL. Atomoxetine should not be used during pregnancy unless the potential benefit justifies the potential risk to the foetus.Atomoxetine and/or its metabolites were excreted in the milk of rats. Patients should be advised to use caution when driving a car or operating hazardous machinery until they are reasonably certain that their performance is not affected by atomoxetine.In paediatric placebo-controlled trials, headache, abdominal painAssociated with decreased appetite, some patients experienced growth retardation early in therapy in terms of both weight and height gain.
You should talk to your doctor first before you stop treatment.Things your doctor will do when you are on treatmentThey will also be done when the dose is changed. In each of the six trials, atomoxetine was statistically significantly superior to placebo in reducing ADHD signs and symptoms (Table X). This is equivalent to 3.3 % of the recommended maximum daily dietary intake of sodium for an adult.This medicine contains 0.8 mg of sodium benzoate in each mL.Strattera oral solution is available in a bottle. Warfarin, acetylsalicylic acid, phenytoin, or diazepam did not affect the binding of atomoxetine to human albumin. It is not recommended to mix Strattera oral solution in food or water as it can prevent the patient receiving a full dose or could negatively affect the taste. The pack also includes a dosing device consisting of a 10 mL oral syringe marked in 1 mL increments and a press-in-bottle adaptor.Strattera oral solution is available in a pack containing one bottle and in a multipack of three bottles. Oral solution, 4 mg/mL (clear colourless) Strattera oral solution is available in a bottle with a child resistant cap containing 100 mL of solution. The incidence of these findings is within historical control values. Also very rarely, severe liver injury, including acute liver failure, have been reported. In a randomised, double-blind, placebo-controlled, abuse-potential study in adults comparing effects of atomoxetine and placebo, atomoxetine was not associated with a pattern of response that suggested stimulant or euphoriant properties.Strattera has been studied in trials in over 5000 children and adolescents with ADHD. It is not recommended to mix Strattera oral solution in food or water as it can prevent the patient receiving a full dose or could negatively affect the taste.Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.Atomoxetine should not be used in combination with monoamine oxidase inhibitors (MAOI).
Talk to your doctor or pharmacist before taking Strattera if you have:Tell your doctor or pharmacist if any of the above applies to you before starting treatment. Strattera administered once daily demonstrated statistically significantly greater reduction in severity of ADHD symptoms compared with placebo as judged by teachers and parents.In a randomised, double-blind, parallel group, 6 week paediatric study to test the non-inferiority of atomoxetine to a standard extended-release methylphenidate comparator, the comparator was shown to be associated with superior response rates compared to atomoxetine.
Such data are insufficient to indicate either an association or a lack of association between atomoxetine and adverse pregnancy and/or lactation outcomes. The acute efficacy of Strattera in the treatment of adults was established in six randomised, double-blind, placebo-controlled trials of ten to sixteen weeks' duration.
These tests will include:Strattera does not need to be taken for ever. Patients who are being treated for ADHD should be carefully monitored for the appearance or worsening of suicide related behaviour.Sudden death has been reported in patients with structural cardiac abnormalities who were taking atomoxetine at usual doses. If any of the following happen, tell an adult you trust straight away. Do not take a double dose to make up for a forgotten dose.If you stop taking Strattera there are usually no side effects but your ADHD symptoms may return.